News Opinion Editor's Corner AHA 2025 What’s Going to Be Hot at AHA 2025? Michael O'Riordan November 05, 2025
Presentation Cardiovascular Interventions 2021 32nd Annual Cardiovascular Interventions Scripps, La Jolla Presenter: Amir Kaki November 19, 2021
News Conference News TCT 2021 Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year L.A. McKeown November 05, 2021
News Opinion Conversations in Cardiology Conversations in Cardiology: Will Insurance Cover Cath in Asymptomatic Patients? June 04, 2021
News Features Cardiac Care Feels Staffing Crunch as Big Money Converts COVID-19 Travelers Shelley Wood January 20, 2021
News Opinion Conversations in Cardiology Conversations in Cardiology: Where to Build a Hybrid Lab December 28, 2020
News Features ‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19 Michael O'Riordan April 07, 2020
News Daily News Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals Michael O'Riordan January 16, 2020
Presentation Cardiovascular Interventions 2019 Same Day Discharge Has Been the Standard at Scripps for Almost 10 Years, but Not Ever Presenter: James Hermiller November 02, 2019
News Industry News Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels February 26, 2018
News Daily News FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market Yael L. Maxwell February 26, 2018
News Conference News TCT 2017 Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors Todd Neale October 30, 2017
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017
News Conference News EuroPCR 2017 Slimmest Stent to Date Looks Promising in Small Study Shelley Wood May 19, 2017
News Industry News Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year May 18, 2017
News Conference News TCT 2016 LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years Yael L. Maxwell October 30, 2016
News Conference News TCT 2016 ‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent Michael O'Riordan October 30, 2016
News Conference News TCT 2016 ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI Shelley Wood October 30, 2016
News Features The Bioresorbable Stent Story So Far: What Promise? What Price? Michael O'Riordan August 17, 2016
News Industry News Real-World Study Shows 72 Percent of Atrial Fibrillation Would Have Gone Undiagnosed in Stroke Patients if Cardiac Monitoring Had Been Limited to 30 Days April 20, 2016